Document is current
Any future updates will be listed below
-
Authors
Kim, Eunyeon
Oh, Il Young
Seo, Jungho
Ha, Sangwook
Kwon, Byungso
Suh, Hyun Seung
Lee, Bo Won
Hong, Hyun Joon
Lee, Seunghee
Kim, Jae Young
Nam, Jeong Sun
-
Funding
Funding for this research was provided by:
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
JETEMA CO., LTD. (jetema-2021)
- License Information
-
More Information
Article History
Received: 1 July 2025
Accepted: 13 February 2026
First Online: 11 April 2026
Declarations
:
: Eunyeon Kim is an investigator, speaker, consultant for and an external clinical expert on a medical device risk management team of JETEMA Co., Ltd. Jungho Seo and Byungso Kwon are lecturers and investigators for JETEMA Co., Ltd. Both Jae Young Kim and Jeong Sun Nam are the chief executive officers of JETEMA Co., Ltd., both of whom participated as a co-author of the current study to endorse the social sustainability of a medical device under European Union Medical Device Regulations 2017/745. But other authors declare no conflicts of interest to declare.
